Kankakee,
28
March
2017
|
04:29 PM
America/Chicago

Riverside Healthcare Upgrades 3D Breast Biopsy Technology

Dr. Ravi Ramakrishna, Breast Radiologist at Riverside Breast Center
"Personally I have had many patients who have had cancers detected early or only with 3D mammography," said Dr. Ravi Ramakrishna, Breast Radiologist at Riverside Breast Center. "The addition of 3D biopsy will allow us to accurately evaluate these abnormalities, often detecting cancers at the earliest stage. This gift greatly supports our continued ability to provide the best care for patients at Riverside."
Dr. Ravi Ramakrishna, Breast Radiologist at Riverside Breast Center

Ta Ta Trot Organization's generous gift helps more patients receive care locally

KANKAKEE, IL (March 28, 2017) - Riverside Healthcare is pleased to announce the upgrade and implementation of 3D breast biopsy equipment at the Riverside Breast Center, an advancement made possible in part by a gift from the Ta Ta Trot Organization. This newly available technology enables patients to stay in the community, instead of traveling as far as Chicago or Peoria for care. 

Riverside's current 3D mammography technology allows radiologists to find even the smallest abnormalities in breast tissue. The implementation of this new biopsy capability makes it possible to sample the area in question and determine if it is an early cancer or another abnormality that needs to be removed.

Because of their passion for keeping care local, the Ta Ta Trot Organization sponsored one third of the Riverside Healthcare Foundation's strategic capital investment for Riverside's 3D breast biopsy upgrade. Additional funding for the approximate $25,000 investment was provided by community gifts designated to breast cancer care through the Riverside Healthcare Foundation. 

"Personally I have had many patients who have had cancers detected early or only with 3D mammography," said Dr. Ravi Ramakrishna, Breast Radiologist at Riverside Breast Center. "The addition of 3D biopsy will allow us to accurately evaluate these abnormalities, often detecting cancers at the earliest stage. This gift greatly supports our continued ability to provide the best care for patients at Riverside."

The 3D biopsy upgrade increases patient convenience and comfort by allowing for comprehensive care locally, reducing wait times to evaluate abnormalities, and eliminating the need to travel to an unfamiliar facility for biopsies.

Learn more about Riverside's comprehensive approach to breast health by visiting riversidehealthcare.org/breast-health.

Boilerplate

Riverside Medical Center is located in Kankakee, Illinois, and is part of Riverside Healthcare, a fully-integrated healthcare system serving the needs of patients throughout five Illinois counties including Kankakee, Iroquois, Livingston, Will, Grundy and parts of Western Indiana. Riverside Medical Center is a 312-bed Level II Trauma hospital that provides a full scope of inpatient and outpatient care. Offering award-winning programs in heart care, cancer care, neurosurgery, orthopedics and a reputation for nursing excellence has placed Riverside as a leader nationally and locally. Riverside is the area's only Magnet® Recognized hospital and ranks among the top 5 percent of hospitals nationwide for clinical performance. The healthcare system has earned Truven Health's Top 100 Hospitals award eight times and is a multi-year recipient of Healthgrades Distinguished Hospital for Clinical Excellence Award. Riverside Medical Group includes more than 140 primary and specialty care providers that deliver care at sites throughout the region. Learn more about Riverside Healthcare at www.RiversideHealthcare.org.